Roche Launches New DNA Sequencing Platform AXELIOS 1
Roche has launched AXELIOS 1, a single-molecule sequencing platform that uses sequencing by expansion technology to deliver same-day whole-genome results.
Tag: next-generation sequencing
All
Latest
All
Latest
New Cancer Guidelines Recommend Molecular Testing for All Pancreatic Cancer Stages
The NCCN now recommends comprehensive molecular profiling for all pancreatic cancer patients eligible for therapy, regardless of stage, to better guide targeted treatment and clinical trial enrollment.
All
Latest
Genome Detective Unveils Automated Pathogen Genomics Platform
The cloud-based system aims to address the bottleneck of translating raw genomic data into actionable information for clinical laboratories.
Next-Generation Sequencing Library Prep System for Lower-Throughput Labs Launches
n6 has launched the icon16, a 16-well NGS library prep instrument for low-throughput clinical and research labs, featuring per-well real-time amplification control using the company’s AutoNorm technology.
Read More
New IVD Assay Kits Bring Standardized NGS Workflows to Oncology Diagnostics
Powered by anchored multiplex PCR chemistry, the in vitro diagnostic offerings target fusion and variant detection for molecular pathology laboratories.
Read More
FDA Approves MyChoice CDx as Companion Diagnostic for Zejula in Ovarian Cancer
The approval makes MyChoice CDx the sole FDA-approved test in the US to identify HRD-positive patients eligible for niraparib maintenance therapy.
Read More
Study Finds Multi-Omic Breast Cancer Test Predicts Radiation Therapy Benefit
Data show the test can predict both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer.
Read More
SPT Labtech Partners to Develop Automated Genomics Platform for Smaller Labs
The collaboration aims to develop an automated genomics platform for decentralized labs, aiming to expand access to streamlined NGS workflows in oncology.
Read More
Illumina Announces NovaSeq X Performance Upgrades Including Q70 Quality Scores
Illumina has announced an 18-month roadmap for NovaSeq X, featuring a 40% output increase to 35 billion reads, faster turnaround times, new flow cell options, and the introduction of Q70 quality scores.
Read More
Ultima Genomics Partners with Hamilton to Automate NGS Sample Preparation
Ultima Genomics and Hamilton have partnered to automate NGS sample preparation and amplification workflows, integrating Ultima’s sequencing systems with Hamilton’s Microlab STAR liquid handling platform to improve lab efficiency.
Read More
NeoGenomics Launches PanTracer Pro for Solid Tumor Testing
The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.
Read More
Thermo Fisher Introduces Sequential Protein/DNA/RNA Extraction Kit
Thermo Fisher Scientific has launched a kit enabling sequential extraction of protein, DNA, and RNA from a single sample, supporting multi-omics cancer research and downstream mass spectrometry and sequencing applications.
Read More
New England Biolabs Releases Magnetic Bead Kit for Cell-Free DNA Extraction
The automation-compatible system works with plasma, serum, urine and cerebrospinal fluid samples from 1 ml to 4 ml input volumes.
Read More
Watchmaker Genomics Licenses CRISPR Technology to Improve DNA Sequencing Efficiency
The company plans to use CRISPR-Cas9 as a binding tool to address bottlenecks in next-generation sequencing workflows.
Read More
Flow Cytometry Blood Test for Myeloma MRD Detection Launches
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.
Read More
New Standards Issued for Liquid Biopsy Cancer Recurrence Tests
The BLOODPAC Consortium has released new analytical validation standards for liquid biopsy MRD tests, offering industry-wide protocols for tumor-informed ctDNA assay development, as detailed in JCO Precision Oncology.
Read More
New Method Shows Superior Sensitivity in Liquid Biopsy Testing
Bridge Capture, a targeted NGS method, showed higher sensitivity for detecting rare ctDNA variants than two leading liquid biopsy assays, according to research in The Journal of Molecular Diagnostics.
Read More
Whole-Genome Sequencing Algorithm Shows Promise for PARP Inhibitor Selection
Weill Cornell Medicine researchers report a whole-genome sequencing algorithm may identify more patients for PARP inhibitor cancer therapies than current commercial tests, according to a study in Communications Medicine.
Read More